Jennifer Champoux
Directeur des opérations chez MONTE ROSA THERAPEUTICS, INC.
Profil
Ms. Jennifer Champoux is a Chief Operating Officer at Monte Rosa Therapeutics, Inc. Ms. Champoux was previously employed as an Executive Director-Operations by H3 Biomedicine, Inc. She received her graduate degree from Indiana University.
Postes actifs de Jennifer Champoux
| Sociétés | Poste | Début |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Directeur des opérations | 01/03/2021 |
Anciens postes connus de Jennifer Champoux
| Sociétés | Poste | Fin |
|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Corporate Officer/Principal | - |
Formation de Jennifer Champoux
| Indiana University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
